Shree Ganesh Remedies Limited (NSE:SGRL)

Shree Ganesh Remedies Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	173.96	134.2	99.72	158.54	111.5	38.83
Short-Term Investments	113.78	-	-	-	-	-
Trading Asset Securities	-	124.54	182.58	46.59	-	-
Cash & Short-Term Investments	287.74	258.74	282.3	205.12	111.5	38.83
Cash Growth	-14.60%	-8.34%	37.62%	83.96%	187.14%	-41.07%
Accounts Receivable	211.21	325.65	222.7	203.33	279.23	183.8
Other Receivables	5.87	1.76	8.54	0.07	50.31	39.32
Receivables	217.08	327.41	231.24	203.4	349.65	273.82
Inventory	335.29	240.05	220.18	249.88	181.76	136.41
Prepaid Expenses	-	10.09	6.01	7.83	-	-
Other Current Assets	35.41	22.36	36.03	35.78	-	-0
Total Current Assets	875.52	858.65	775.75	702.01	642.92	449.06
Property, Plant & Equipment	1,172	1,170	1,033	971.06	764.46	298.18
Long-Term Investments	0.8	1.17	0.82	0.85	4.77	11.59
Goodwill	-	-	-	-	1.88	3.76
Other Intangible Assets	6.17	5.13	4.7	3.65	3.59	0.93
Long-Term Deferred Tax Assets	-	-	-	-	0.85	-
Long-Term Deferred Charges	-	-	-	-	0.23	0.5
Other Long-Term Assets	48.53	41.87	105.01	31.78	19.64	6.14
Total Assets	2,103	2,077	1,919	1,709	1,438	770.16

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	148.4	94.42	59.67	81.88	145.34	94.74
Accrued Expenses	0.36	13.69	10.76	9.77	4.49	5.2
Short-Term Debt	-	0.21	0.17	7.1	15.66	-
Current Portion of Long-Term Debt	53.69	94.04	87.46	64.83	10.09	-
Current Portion of Leases	-	0.13	0.13	0.14	-	-
Current Income Taxes Payable	2.53	5.56	-	14.68	58.48	46.46
Other Current Liabilities	14.77	8.88	3.63	8.43	3.34	4.01
Total Current Liabilities	219.75	216.92	161.82	186.81	237.4	150.4
Long-Term Debt	206.21	212.48	294.82	291.19	309.32	-
Long-Term Leases	1.49	1.27	1.26	1.25	-	-
Pension & Post-Retirement Benefits	6.24	5.74	4.64	3.34	2.24	2.03
Long-Term Deferred Tax Liabilities	12.11	10.8	5.3	5.79	-	2
Total Liabilities	445.8	447.21	467.85	488.37	548.96	154.42

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	128.38	128.38	128.38	128.43	125.11	120.07
Additional Paid-In Capital	-	224.09	224.09	225.33	154.99	50.05
Retained Earnings	-	1,276	1,098	867.22	609.02	445.62
Comprehensive Income & Other	1,529	1.35	1.31	0	0.25	-
Total Common Equity	1,657	1,630	1,452	1,221	889.37	615.74
Shareholders' Equity	1,657	1,630	1,452	1,221	889.37	615.74
Total Liabilities & Equity	2,103	2,077	1,919	1,709	1,438	770.16

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	261.39	308.13	383.84	364.49	335.07	-
Net Cash (Debt)	26.35	-49.39	-101.55	-159.37	-223.57	38.83
Net Cash Growth	-	-	-	-	-	-39.08%
Net Cash Per Share	2.05	-3.85	-7.91	-12.67	-18.21	3.18
Filing Date Shares Outstanding	12.83	12.84	12.84	12.85	12.85	12.01
Total Common Shares Outstanding	12.83	12.84	12.84	12.85	12.85	12.01
Working Capital	655.78	641.73	613.93	515.2	405.52	298.67
Book Value Per Share	129.15	126.95	113.07	95.04	69.23	51.28
Tangible Book Value	1,651	1,625	1,447	1,217	883.9	611.05
Tangible Book Value Per Share	128.66	126.55	112.70	94.75	68.80	50.89
Land	-	-	-	-	141	72.05
Buildings	-	220.51	197.42	133.2	74.36	68.85
Machinery	-	823.77	653.16	493.59	310.26	269.93
Construction In Progress	-	123.78	83.44	166.27	417.66	30.93

Data Source: S&P Global Market Intelligence Last updated: Oct 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 9, 2026

Data Sources Report a data error